The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...
The U.S. Supreme Court appeared skeptical Tuesday of the government's attempt to limit the number of Food and Drug ...
The Trump administration’s food regulatory agenda will come into sharper focus once nominees for the U.S. Department of Health and Human ...
The FDA says vaping companies are improperly gaming the court system, filing claims in an appeals court they think will be ...
Recent home price increases, though intensified by the unique circumstances of the COVID-19 pandemic, reflect a broader trend of above-average growth following economic recessions. Historically, U ...
Medpage Today on MSN2d
What to Know About Abortion Developments in the States, Courts as Trump Takes OfficeThree States Can Keep Trying to Roll Back Abortion Pill Access. Most U.S. abortions are now performed with medication rather than surgic ...
The decision to move Monday's swearing-in means thousands of people with plans to visit Washington won’t be able to see President-elect Donald Trump’s second inauguration in person. (AP Video: Nathan ...
A proposed Mississippi bill would let bounty hunters track undocumented migrants. The DeSoto County DA announced it this week. Here's what we know.
The FDA added a boxed warning about rare cases of anaphylaxis associated with the multiple sclerosis (MS) drug glatiramer ...
The FDA has added a boxed warning, its most serious designation, to Copaxone and Glatopa due to the risk of anaphylaxis, a rare but serious allergic reaction. This severe reaction can occur at any ...
Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback